Research
April 13, 2011
Cancer surveillance expands in Georgia
The Surveillance, Epidemiology, and End Results (SEER) Registry in Georgia will be funded to cover the entire state.
The Georgia Center for Cancer Statistics (GCCS) at Emory has been awarded funding by the National Cancer Institute to expand the Surveillance, Epidemiology, and End Results (SEER) Registry in Georgia to cover the entire state.
This is a major advance for existing statewide cancer surveillance activities in Georgia, says Kevin C. Ward, GCCS director.
The additional funding will be used by researchers and clinicians throughout the state to:
• Enhance the timeliness, quality and completeness of cancer surveillance data;
• Support active follow-up of patients for statewide survival analyses;
• Expand coverage and implementation of electronic pathology reporting;
• Link to external sources to enhance the registry’s data; and
• Provide new channels for data utilization and dissemination.
The SEER Program was established in the early 1970s following the National Cancer Act of 1971.
SEER is an authoritative source of information on cancer incidence and survival in the United States and is the only comprehensive source of long-term population-based cancer data, including detailed stage of disease at the time of diagnosis and corresponding patient survival.
The GCCS, a surveillance research center of the Department of Epidemiology in the Rollins School of Public Health, was originally founded in 1975 to provide population-based cancer incidence data for Clayton, Cobb, DeKalb, Fulton and Gwinnett counties.
